Sample Data. (a) Corvus and Genentech will each generate data [***]. Each Party shall [***] Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions. provide to the other Party the results and/or analysis generated in the course of performing Sample Analyses for both the single agent arm and the Combination arm via electronic data transfer or other format/media determined by the JDC. Such results and/or analysis shall be provided to the other Party within [***] of completion of the assay or as otherwise agreed by the JDC.
(b) Corvus shall own all right, title and interest in and to [***] shall be deemed Corvus Confidential Information.
(c) Corvus and Genentech shall [***] (collectively “[***] Sample Data”). [***] Sample Data shall be deemed Joint Confidential Information.
Sample Data. Sample Data may be made available to You as part of the Snowflake Service. You acknowledge that Sample Data is example data only, which may not be complete, current, or accurate. You will not (and will not permit any third-party to) copy or export any Sample Data and You agree that the Sample Data may be deleted at any time or You may be required to cease using Sample Data at any time.
Sample Data. Customer may use the Sample Data provided with the Software and, as applicable, the Service Products to test, evaluate and demonstrate features of the Software and, as applicable, the Service Products, and for no other purpose.
Sample Data. Sponsor or its designees will test Biological Samples as described in the Protocol. Unless otherwise specified in the Protocol, Sponsor will not provide the results of such tests (“Sample Data”) to the Provider or Principal Investigator or Trial Subject. Sample Data will be treated as Trial Data; therefore, if Sponsor provides Sample Data to the Provider or Principal Investigator, that data will be subject to the permitted use of Trial Data as outlined in this Agreement. 12.
Sample Data. Snowflake may make available sample data (including from third-party sources) solely for Customer’s internal testing, evaluation, and other non-productive use during the applicable Subscription Term (“Sample Data”). Customer acknowledges that Sample Data is example data only, which may not be complete, current, or accurate. Customer will not (and will not permit any third party to) copy or export any Sample Data and agrees that Snowflake may delete or require Customer to cease using Sample Data at any time.
Sample Data. Upon Customer’s request and at D&B’s discretion, D&B may provide a limited amount of Information to Customer for a period of thirty (30) days for evaluation purposes only and not for any commercial or production purposes (“Sample Data”). Sample Data will be designated as sample data or proof of concept data. The terms of this Master Agreement will apply to D&B’s provision and Customer’s use of any Sample Data, except that Sample Data is provided without warranty of any kind.
Sample Data. Seller shall provide to Buyer, a machine-readable data tape of all of Seller S&L's loan and deposit accounts, together with a written description of the file, record, and field data types and formats, to allow Buyer to prepare for a data processing conversion, at a date prior to Closing agreed upon between Buyer and Seller. The data tape shall include summary interest accrual and payment information for the current year to date, except that the name and address information may, at Seller's option, be encoded in such a way that the actual identities of Seller S&L's customers cannot be determined.
Sample Data. Sponsor or its designees will test Biological Samples as described in the Protocol. Unless otherwise specified in the Protocol, Sponsor will not provide the results of such tests (“Sample Data”) to the Institution or Study Subject. Sample Data will be treated as Study Data; therefore, if Sponsor provides Sample Data to the Institution, akýmkoľvek úsilím o obchodné použitie, ktoré môžu on alebo jeho zástupcovia vynaložiť v súvislosti so skúšaným produktom alebo ako výsledok štúdie. Zdravotnícke zariadenie musí, a zabezpečí, že personál zdravotníckeho zariadenia bude, plne spolupracovať so zadávateľom, vrátane podpisu akýchkoľvek dodatočných dokumentov potrebných na podporu práv zadávateľa podľa tohto dokumentu. Zdravotnícke zariadenie prijme primerané a obvyklé bezpečnostné opatrenia, vrátane pravidelnej zálohy počítačových súborov, aby zabránilo strate alebo zmene akýchkoľvek údajov štúdie. b.
Sample Data. (a) Each Party will be responsible for conducting the Sample Analysis for its own Investigational Product; the Party responsible for conducting Sample Analysis for the Combination will be set forth in the Sample Analysis Plan. Kite and Humanigen will each generate data (including raw data), findings, conclusions and other results in conducting such Sample Analyses for Samples obtained from the Study (“Sample Data”). Each Party shall provide to the other Party the results and/or analysis generated in the course of performing Sample Analyses for the Study via electronic data transfer or other format/media determined by the JDC. Such results shall be provided to the other Party within thirty (30) days of completion of the analysis or as otherwise set forth in the Sample Analysis Plan or otherwise agreed by the JDC.
(b) Kite shall solely own all Sample Data that relate solely to the Kite Investigational Product. Humanigen shall solely own all Sample Data that relate solely to the Humanigen Investigational Product. Except to the extent otherwise agreed in writing by an authorized representative of each Party, each Party shall use the other Party’s Sample Data only for the purposes of (i) seeking regulatory approval for the use of its Investigational Product in the Combination, and (ii) filing and Prosecuting Patent applications for Collaboration Inventions and enforcing any resulting Patents in accordance with Article 6. Further, Kite shall have the right to access and use Humanigen Sample Data for the purpose of performing correlative analysis(es) with the Kite Sample Data. The Parties shall jointly own Sample Data that relate solely to the Combination, and not solely to an Investigational Product. Such jointly owned Sample Data shall be deemed Joint Confidential Information. For clarity, and by way of example, the results of the correlative analysis(es) to be performed by Kite with use of the Humanigen Sample Data and Kite Sample Data relates solely to the Combination, shall be jointly owned by the Parties, and shall be deemed jointly owned Sample Data and Joint Confidential Information. Each Party has the right to use the jointly owned Sample Data for any lawful purpose; provided, however, each Party’s use of the jointly owned Sample Data is subject to: (i) Section 6.3(e); (ii) the limitations on disclosure of the other Party’s Confidential Information in Section 2.6(c) and Article 7; (iii) the limitations on disclosure of Joint Confidential Information in S...
Sample Data. (a) Corvus and Genentech will each generate data [***]. Each Party shall [***] Certain information in this document has been excluded pursuant to Regulation S-K, Item 601(b)(10). Such excluded information is not material and would likely cause competitive harm to the registrant if publicly disclosed. provide to the other Party the results and/or analysis generated in the course of performing Sample Analyses for both the single agent arm and the Combination arm via electronic data transfer or other format/media determined by the JDC. Such results and/or analysis shall be provided to the other Party within [***] of completion of the assay or as otherwise agreed by the JDC.
(b) Corvus shall own all right, title and interest in and to [***] shall be deemed Corvus Confidential Information.
(c) Corvus and Genentech shall [***] (collectively “[***] Sample Data”). [***] Sample Data shall be deemed Joint Confidential Information.
